Overview
Postprocedural mitral valve regurgitation (MR) is a common complication following mitral valve surgery, characterized by the backflow of blood from the left ventricle into the left atrium during systole. This condition can significantly impact cardiac function, leading to reduced ejection fraction, heart failure symptoms, and decreased quality of life. It predominantly affects patients who have undergone surgical interventions for mitral valve disease, including repair or replacement. Early identification and management of postprocedural MR are crucial in day-to-day practice to prevent long-term complications and improve patient outcomes 1.Pathophysiology
Postprocedural mitral valve regurgitation arises from various mechanisms that disrupt the normal function of the mitral valve apparatus. Surgical interventions, while aimed at correcting valve pathology, can inadvertently damage valve leaflets, chordae tendineae, or papillary muscles, leading to structural abnormalities. These alterations can result in incomplete valve closure, allowing blood to regurgitate during systole. Additionally, inflammation and fibrosis post-surgery may contribute to leaflet tethering and restricted motion, further exacerbating MR. The severity of MR often correlates with the extent of surgical trauma and the underlying valve pathology preoperatively. Factors such as preoperative left atrial size and the presence of atrial fibrillation can also influence the development and persistence of postprocedural MR 1.Epidemiology
The incidence of postprocedural mitral valve regurgitation varies based on surgical techniques and patient-specific factors. While precise incidence figures are not provided in the given source, studies suggest that MR can occur in a significant proportion of patients post-mitral valve surgery, often ranging from mild to severe grades. Patients typically include those with a history of rheumatic heart disease, degenerative valve disease, and those undergoing complex procedures like combined Maze and mitral valve surgery. Age and preoperative left atrial dimensions are notable risk factors, with older patients and those with larger left atria being at higher risk. Trends indicate an increasing awareness and focus on minimizing MR through advanced surgical techniques and postoperative management strategies 1.Clinical Presentation
Postprocedural mitral valve regurgitation often presents with symptoms related to reduced cardiac efficiency, including dyspnea, fatigue, and exercise intolerance. Patients may also experience palpitations or signs of heart failure such as edema and pulmonary congestion. Red-flag features include acute onset of symptoms post-surgery, unexplained weight gain, and signs of hemodynamic instability like hypotension or syncope. These presentations necessitate prompt evaluation to differentiate from other postoperative complications and to guide timely intervention 1.Diagnosis
The diagnostic approach for postprocedural mitral valve regurgitation involves a combination of clinical assessment and imaging techniques. Echocardiography, particularly transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE), is pivotal in quantifying the degree of MR, assessing valve anatomy, and identifying potential causes such as leaflet prolapse or chordal rupture. Specific criteria for diagnosis include:(Evidence: Moderate) 1
Management
Initial Management
The initial management of postprocedural mitral valve regurgitation focuses on supportive care and monitoring:Intermediate Management
If medical management fails or MR is moderate to severe, further interventions may be necessary:Refractory Cases
For patients with refractory MR and significant symptoms despite interventions:(Evidence: Moderate) 1
Complications
Postprocedural mitral valve regurgitation can lead to several complications:Management triggers include worsening symptoms, significant LVEF decline, or echocardiographic evidence of progressive MR. Referral to a cardiothoracic surgeon is warranted for surgical reevaluation 1.
Prognosis & Follow-up
The prognosis of patients with postprocedural mitral valve regurgitation varies based on the severity and management efficacy. Key prognostic indicators include:Recommended follow-up intervals include:
(Evidence: Moderate) 1
Special Populations
Elderly Patients
Elderly patients undergoing mitral valve surgery are at higher risk for postprocedural MR due to comorbid conditions and reduced healing capacity. Management should focus on minimizing surgical trauma and aggressive medical support post-surgery.Patients with Preoperative Atrial Fibrillation
Those with preoperative atrial fibrillation have a higher risk of recurrence post-surgery, which can exacerbate MR and heart failure symptoms. Strategies to maintain sinus rhythm, such as antiarrhythmic medications and rhythm control therapies, are crucial.(Evidence: Moderate) 1
Key Recommendations
References
1 Kasemsarn C, Porapakkham P, Wathanawanichakun S, Lerdsomboon P, Chanpa K. Long-Term Outcomes of Concomitant Modified Cox-Maze and Mitral Surgery. Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 2025. link